TGFB1 and lung cancer: Finally, Berchem et al. showed that following their uptake by NK (natural killer) cells, vesicles derived from hypoxic lung cancer release TGF-β1 (transforming growth factor, beta) to decrease the cell surface expression of the activating receptor NKG2D (NK cell receptor D) inhibiting NK cell functions [36].